Latest updates, from us and our ventures
Q1 2019
This week's #InTheWordsOf comes from British editor and educational writer, William Edward Hickson.… https://t.co/oEp8JnTOro
— Leaps by Bayer (@LeapsByBayer) March 20, 2019
Our CSO Andy Scharenberg spoke on several panels at the ‘In Vivo #GeneTherapy and #GeneEditing Summit’. Thanks to t… https://t.co/fHqZoT06Nd
— Casebia Therapeutics (@casebiatx) March 19, 2019
Following He Jiankui's announcement of the birth of twins with edited genomes, the science community has been beset… https://t.co/ApMvXGE38f
— Leaps by Bayer (@LeapsByBayer) March 18, 2019
We’re delighted to announce Dr. Joachim Fruebis is joining @BlueRockTx as our new Chief Development Officer, as we… https://t.co/6whnVJ6skT
— BlueRock (@BlueRockTx) March 18, 2019
Ginkgo Bioworks is launching a new spinoff company called Motif Ingredients which will work on developing proteins… https://t.co/lRKuZ95O32
— Leaps by Bayer (@LeapsByBayer) March 15, 2019
We were proud to participate with @Bayer for the recent SF #STEM Career Day. @SFUnified high school students toured… https://t.co/wWvbWVmn4F
— Casebia Therapeutics (@casebiatx) March 13, 2019
'Why does replacing Alzheimer’s patients’ plasma with albumin seem to help their brains? Learn more about the first… https://t.co/HAq78mgvD0
— Leaps by Bayer (@LeapsByBayer) March 13, 2019
The Premier of Ontario, @fordnation, visited the BlueRock lab and met with our team today! #Toronto continues to be… https://t.co/tDb31zoq7j
— BlueRock (@BlueRockTx) March 11, 2019
We were very proud to help sponsor the @iine International Women's Day luncheon today. Members of our #Cambridge te… https://t.co/Dt0un5o1Xh
— Casebia Therapeutics (@casebiatx) March 08, 2019
Great to celebrate our VP, Head of #Legal @RobinWalker last night as she was honored as one of @masslw 2019 In-Hous… https://t.co/QBx8ePWdsl
— Casebia Therapeutics (@casebiatx) March 07, 2019
RT @TTI_TPRM: Ainslie Little @BlueRockTx speaking to us about IP and Regenerative Medicine today #regenmed @OIRMnews @StemCellNetwork @McEw…
— BlueRock (@BlueRockTx) March 07, 2019
RT @LeapsByBayer: 'For those suffering from intractable diseases, there is a journey and, perhaps some hope'. Kemal Malik, Board Member at…
— BlueRock (@BlueRockTx) March 07, 2019
'For those suffering from intractable diseases, there is a journey and, perhaps some hope'. Kemal Malik, Board Memb… https://t.co/7mslD5ekbc
— Leaps by Bayer (@LeapsByBayer) March 07, 2019
BlueRock CEO Emile Nuwaysir will be presenting at Cowen and Company’s 39th Annual Health Care Conference on Tuesday… https://t.co/EEG67iz3YB
— BlueRock (@BlueRockTx) March 05, 2019
'Leaps is a unique approach in accessing breakthrough innovations and fundamental solutions in health and nutrition… https://t.co/2D04lFsdYE
— Leaps by Bayer (@LeapsByBayer) March 05, 2019
RT @science_eclub: #ThrowbackThursday: Building The Future And Working In #venture What goes on in the mind of an #investor, how do you ev…
— Leaps by Bayer (@LeapsByBayer) March 05, 2019
Our Cambridge and Mission Bay offices came together to learn more about rare diseases and their impact on patients.… https://t.co/TqHdteT2Em
— Casebia Therapeutics (@casebiatx) February 28, 2019
Here at Casebia, we are determined to create a better quality of life for those afflicted by rare diseases. https://t.co/P0HqWmXJwN
— Casebia Therapeutics (@casebiatx) February 28, 2019
#WorldRareDiseaseDay takes place on the last day and February annually and its main objective is to bring awareness… https://t.co/b0lKpecB0L
— Casebia Therapeutics (@casebiatx) February 28, 2019
Looking back at the career of Jane Goodall, who by age 26 had already made several groundbreaking discoveries, maki… https://t.co/FtZ8wFJ0dZ
— Leaps by Bayer (@LeapsByBayer) February 28, 2019
1 of our 3 core therapeutic areas is #cardiology. We’re proud to recognize #HeartHealthMonth as we work to make a s… https://t.co/rpb6PhW7BT
— BlueRock (@BlueRockTx) February 28, 2019
Today is #WorldRareDiseaseDay and our team at @casebiatx would like to help bring awareness to the rare diseases th… https://t.co/u8CkgvUyZa
— Casebia Therapeutics (@casebiatx) February 28, 2019
This week's #InTheWordsOf comes from French-Polish physicist and chemist, Marie Curie. #ReturnForHumanity… https://t.co/VtKlGfJV7n
— Leaps by Bayer (@LeapsByBayer) February 27, 2019
Diversity is a key factor in terms of innovation, so how to tackle the issue of under-representation of minority gr… https://t.co/Vo2VS0LAxp
— Leaps by Bayer (@LeapsByBayer) February 27, 2019
Pioneering polymer recycling from @wornagainuk, can separate, decontaminate and extract materials to make new raw t… https://t.co/CzQ15mOOuw
— Leaps by Bayer (@LeapsByBayer) February 26, 2019
From walking to the shops, to chopping onions. These researchers say that moving more might be the key to a sharp m… https://t.co/wBR9OAWrhG
— Leaps by Bayer (@LeapsByBayer) February 25, 2019
To celebrate #HeartHealthMonth, we hosted our very own Cardiac Research Day! BlueRockers presented all day to showc… https://t.co/myyAq8j7dj
— BlueRock (@BlueRockTx) February 21, 2019
These bioengineers are using 3D printers to make more durable hip and knee joints, prosthetic limbs and recently, t… https://t.co/A1yYKCssM9
— Leaps by Bayer (@LeapsByBayer) February 21, 2019
This isn’t your run of the mill kindergarten. This Play Lab is part of a global experiment to bring play and its be… https://t.co/SDrF8fRuY2
— Leaps by Bayer (@LeapsByBayer) February 20, 2019
At #BlueRock, we make teamwork & fun a priority. Our favorite winter activity is “synchronized” ice skating in our… https://t.co/5FiP4yXyFh
— BlueRock (@BlueRockTx) February 19, 2019
Recently members of our team toured the Institute for Ophthalmic Research lab in Tübingen, #Germany. Thanks to Dr.… https://t.co/0eMkJMjVSo
— Casebia Therapeutics (@casebiatx) February 12, 2019
For a better understanding of the scale and purpose of our mission, join Dr. Axel Bouchon and Kemal Malik as they d… https://t.co/PshZWdDu5T
— Leaps by Bayer (@LeapsByBayer) February 11, 2019
The teams from our #SanFrancisco and #Cambridge offices joined together recently at our All Hands Meeting to share… https://t.co/59NMlfzwwO
— Casebia Therapeutics (@casebiatx) February 08, 2019
Child psychologist Maren Østvold Lindheim is radically harnessing the healing and restorative powers of nature. Is… https://t.co/x6cxZzlHrU
— Leaps by Bayer (@LeapsByBayer) February 07, 2019
As the #PatriotsParade wraps up in #Boston, our #Cambridge team celebrates another Super Bowl victory for the New E… https://t.co/E8Ax0Y1N1n
— Casebia Therapeutics (@casebiatx) February 05, 2019
Dr Ken-Ichiro Kamei's 'bodies on a chip' not only have the potential to improve human medicine, but could also be a… https://t.co/H60DuGyLSS
— Leaps by Bayer (@LeapsByBayer) February 05, 2019
10 people who made a phenomenal difference in their fields in 2018. Plus the ones to watch in 2019.… https://t.co/2cD1CS2HVK
— Leaps by Bayer (@LeapsByBayer) February 04, 2019
RT @alliancerm: Recommended reading: @CasebiaTx Pres & CEO (& ARM board member) Jim Burns details gene editing commercialization challenges…
— Casebia Therapeutics (@casebiatx) February 01, 2019
In a @STATNews First Opinion piece, our CEO Jim Burns highlights the need to tackle the big challenges of #CRISPR-… https://t.co/RyN5oK7Ny0
— Casebia Therapeutics (@casebiatx) February 01, 2019
An exciting new area of cell biology research emerges with Leaps by Bayer to invest into Dewpoint Therapeutics Seri… https://t.co/jr1ItxclQb
— Leaps by Bayer (@LeapsByBayer) January 31, 2019
Join the research programs going on at BlueRock! We are hiring #scientists, an #informatics administrator,… https://t.co/7lmNOtQaDE
— BlueRock (@BlueRockTx) January 30, 2019
We are excited to be part of #ProjectOnramp to offer internships & new opportunities to talented students from unde… https://t.co/6PWeAYg6oy
— Casebia Therapeutics (@casebiatx) January 30, 2019
Not familiar with #CRISPR or the details of gene-editing? Learn what all the fuss is about and join the discussion… https://t.co/q72VO8RuLL
— Leaps by Bayer (@LeapsByBayer) January 29, 2019
Named as one of the top 10 innovators in disruptive #agtech, learn more about the work of our joint venture… https://t.co/NLQNzYVCqv
— Leaps by Bayer (@LeapsByBayer) January 29, 2019
RT @JonnyAcheson: Curtains up on this illustrated story, she asks lots of questions 'My Dad: his Parkinson's through my 9 year old eyes.'…
— BlueRock (@BlueRockTx) January 28, 2019
Ice caps melting in the centre of London: Olafur Eliasson has built a spectacular installation to address climate c… https://t.co/7uiTKj58qf
— Leaps by Bayer (@LeapsByBayer) January 28, 2019
Amy Jennings, Head of #Regulatory Affairs, spoke on the topic of ‘#Manufacturing for #Commercialization: Strategic… https://t.co/O0PzYnXfwW
— Casebia Therapeutics (@casebiatx) January 25, 2019
To paraphrase the inspiring words of @Schwarzenegger, every move we make is based on achieving 10 impossible leaps.… https://t.co/gAZiXuecZO
— Leaps by Bayer (@LeapsByBayer) January 24, 2019
Congratulations to our own VP, Head of #Legal @RobinWalker for being honored as one of Mass. Lawyers Weekly’s (… https://t.co/KFQZUQrlQ0
— Casebia Therapeutics (@casebiatx) January 23, 2019
As the longest US government #shutdown in federal history continues, more and more industries are feeling the pinch… https://t.co/aBsqxLWZCm
— Leaps by Bayer (@LeapsByBayer) January 23, 2019
.@Phacilitate and the @WSCSummit are coming together to host the entire advanced therapies ecosystem! We are excite… https://t.co/Qk20P7iugR
— BlueRock (@BlueRockTx) January 22, 2019
Making the city a cleaner place! Watch to learn about this concrete tested in Poland that filters pollution into sa… https://t.co/O0nBg93LfZ
— Leaps by Bayer (@LeapsByBayer) January 21, 2019
Emile Nuwaysir is leading the BlueRock team to develop our novel #CellplusGene platform. Learn more about our techn… https://t.co/GC62FmIwko
— BlueRock (@BlueRockTx) January 18, 2019
Join the BlueRock team! We are looking for an #IP and #contracts #attorney, #IT associate, head of #IR and an… https://t.co/AnVRgnKbwN
— BlueRock (@BlueRockTx) January 16, 2019
Today our team grows even stronger as we announce partnerships with two leading experts in autoimmune diseases. Wel… https://t.co/enQxJAUqYe
— BlueRock (@BlueRockTx) January 16, 2019
Ever wondered what a wind turbine made out of 146,000 LEGO bricks would look like? @LEGO_Group has built one in ord… https://t.co/Mp0BSIRBwt
— Leaps by Bayer (@LeapsByBayer) January 16, 2019
RT @MichaelJFoxOrg: If you're feeling at a loss for ways to help a friend diagnosed with #Parkinsons disease, start with these suggestions…
— BlueRock (@BlueRockTx) January 14, 2019
What if open brain surgery wasn't necessary anymore? Parkinson's disease faces a potential new and minimal invasive… https://t.co/RWV5fjjVZH
— Leaps by Bayer (@LeapsByBayer) January 14, 2019
What a week! Thank you #SanFrancisco for welcoming us to your city. Yet another productive year at #JPM19! See ever… https://t.co/9j2uTOYomj
— BlueRock (@BlueRockTx) January 10, 2019
A completely cancer-free patient after being diagnosed with and treated for metastatic breast cancer: This is a maj… https://t.co/vLo3sJcXtz
— Leaps by Bayer (@LeapsByBayer) January 10, 2019
Thanks to the @STATNews #Biotech team for hosting The Readout Live at #JPM19. Here's our CEO Jim Burns catching up… https://t.co/cuxJvHE78e
— Casebia Therapeutics (@casebiatx) January 10, 2019
BlueRock's Eric Soller had a great time discussing innovation in CNS drug development and the use of novel… https://t.co/ypDQL4dGmA
— BlueRock (@BlueRockTx) January 09, 2019
A new institute seeded by Paul Allen with $125 million has started studying the immune system in three unprecedente… https://t.co/5H6Eoadksa
— Leaps by Bayer (@LeapsByBayer) January 08, 2019
Earlier today, our CEO Jim Burns joined discussions with @alliancerm CEO Janet Lynch Lambert and other members as p… https://t.co/b3ap3ISvqF
— Casebia Therapeutics (@casebiatx) January 07, 2019
The Casebia team has arrived – we are excited to participate in #JPM19! From today’s ARM (@alliancerm) Cell & Gene… https://t.co/jKcZTlHxph
— Casebia Therapeutics (@casebiatx) January 07, 2019
Thought For Food™ focus on addressing the unique needs and challenges facing the food and agriculture sector, which… https://t.co/x1SRQVxR0t
— Leaps by Bayer (@LeapsByBayer) January 04, 2019
We will be joined by the greatest industry leaders from across the country at the 37th Annual @jpmorgan #Healthcare… https://t.co/OcPQAruxju
— BlueRock (@BlueRockTx) January 02, 2019
Operating the world's first medical drone delivery system, Zipline improves access to scarce supplies like blood an… https://t.co/3WZdz4Au2k
— Leaps by Bayer (@LeapsByBayer) January 02, 2019